Phase I Pharmacokinetic Study of a New 3-Azinomethyl-Rifamycin (Rifametane) as Compared to Rifampicin

Publisher： Karger

E-ISSN： 1421-9794|45|3|147-153

ISSN： 0009-3157

Source： Chemotherapy, Vol.45, Iss.3, 1999-04, pp. : 147-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Docetaxel and Bexarotene

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-03 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

A QSAR, Pharmacokinetic and Toxicological Study of New Artemisinin Compounds with Anticancer Activity

By Vieira Josinete B.   Braga Francinaldo S.   Lobato Cleison C.   Santos César F.   Costa Josivan S.   Bittencourt José Adolfo H. M.   Brasil Davi S. B.   Silva Jocivânia O.   Hage-Melim Lorane I. S.   Macêdo Williams Jorge C.   Carvalho José Carlos T.   Santos Cleydson Breno R.  

Molecules, Vol. 19, Iss. 8, 2014-07 ,pp. : 10670-10697

MDPI

Access to resources Recommend Favorite

Phase I and Pharmacokinetic Evaluation of Intravenous Hyaluronic Acid in Combination with Doxorubicin or 5-Fluorouracil

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 132-141

Karger

Access to resources Recommend Favorite

Effect of Oral Administration of Crude Aqueous Extract of Garlic on Pharmacokinetic Parameters of Isoniazid and Rifampicin in Rabbits

By  

Pharmacology, Vol. 77, Iss. 2, 2006-06 ,pp. : 100-104

Karger

Access to resources Recommend Favorite

A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers

By  

Chemotherapy, Vol. 54, Iss. 3, 2008-06 ,pp. : 236-241

Karger

Access to resources Recommend Favorite